Hope on the Horizon: Advances in Pancreatic Cancer
In this presentation, Dr. Brandon G. Smaglo, Assistant Professor, Department of Medicine, Hematology-Oncology, Baylor College of Medicine, discusses the current state-of-the-art in pancreatic cancer care. Pancreatic cancer is the third leading cause of cancer-related mortality in the United States. Pancreatic cancer that is resectable is associated with favorable outcomes. Outcomes for locally advanced, unresectable pancreatic cancer are poor. Determining resectability requires multidisciplinary case review as well as dedicated imaging of the primary tumor.
Dr. Benjamin Musher, Associate Professor, Department of Medicine, discusses unmet needs and novel treatment options in development for pancreatic cancer. Drs. Musher and Smaglo focus on the novel therapeutics being investigated in clinical trials at BCM’s Dan L. Duncan Comprehensive Cancer Center, including cancer stem cell inhibitors, immune checkpoint inhibitors, and multi-tumor-associated antigen cytotoxic T-lymphocyte therapy.
The following individual(s) has/have reported financial or other relationship(s) with commercial entities whose products/services may relate to the educational content of this activity: